| AMNIOSTART | Chromosome medium |
Instruction for chromosome analysis | HYBRIDOMA medium | HYBRIDOMED DIF
1000 | MCDB 153 Basal | MCDB
153 Complete | OCTOMED | SEBOMED
| PFEK-1 | START V Brain Cell medium |
TNB 100 |
| Back to Catalogue
Contents | Home |
SERUM AND PROTEIN FREE CELL CULTURE MEDIA
|
Media |
Cat No. |
Serum/Protein Free |
Cells/Cell Lines |
|
Coon's F-12 |
F0855 |
serum free if supplemented
accordingly |
FRTL 5 |
|
|
|
|
|
|
HybridoMed / DIF 1000 |
F8035 / 1 |
serum free |
hybridormas |
|
|
F8055 / 1 |
|
|
|
|
|
|
|
|
Iscove's |
F0465 |
serum free if supplemented
accordingly |
lymphocytes |
|
|
|
|
|
|
MCDB 153 |
F8105 |
serum free |
(human) keratinocytes |
|
|
|
|
|
|
octomed |
F8085 |
protein free |
CHO cells |
|
|
|
|
|
|
PFEK-1 |
F8045 |
protein free |
VERO cells |
|
|
|
|
|
|
sebomed |
F8215 |
serum free |
(human) sebocytes |
|
|
|
|
|
|
Start V |
F8075 |
serum free |
neuronal cells |
|
|
|
|
|
|
TNB 100 |
F8023 |
serum free |
neuroblastoma x glioma hybrid
cells, |
|
|
|
|
normal neuronal cells,
cytotoxic T-cells. |
Note: A trypsin inhibitor (cat. no. L2180) might be
required with serum free media!
![]()
Storage: -20OC
Complete medium to grow primary human amniotic fluid
cells, harvested during early pregnancy (approx week 12 - 16). Amniostart
provides a well balanced formulation of salts, amino acids, vitamins, trace
elements, hormones, nucleosides, insulin, transferrin, selenious acid, and
growth factors.
Amniostart contains 20% pretested Fetal Bovine. Serum
(FBS); gentamycin sulphate serves as protective against bacterial
contamination.
Amniostart is available in two different versions,
buffered either with HEPES (
Amniostart has a shelf life of 36 months at -
|
|
Cat.No. |
Unit
|
|
Amniostart |
F5043 |
100 ml |
|
Amniostart with |
F5143 |
100 ml |
![]()
Storage: -20OC
The complete medium is standardized for chromosome
analysis with excellent lot to lot consistancy
Formulation (per 1000 ml)
|
MEM Joklik with non essential amino acids |
850 ml |
|
Fetal Bovine Serum |
150 ml |
|
Heparin |
25000 E |
|
Penicillin G, sodium salt |
75000 E |
|
Streptomycin sulphate |
50 mg |
|
Phytohemagglutinin L* |
2.5 mg |
|
Ascorbic acid |
5 mg |
|
Glutathione (reduced) |
5 mg |
* for Chromosome medium B
|
|
Cat.No. |
Unit
|
|
Chromosome Medium A |
F5013 |
100 ml |
|
without phytohemagglutinin (PHA) L |
|
|
|
|
|
|
|
Chromosome Medium B |
F5023
|
100 ml |
|
with phytohemagglutinin (PHA) L |
|
|
Additives for chromosome analysis:
Storage –20oC
|
|
Cat.No. |
Unit
|
|
COLCHICIN (10 μg / ml) |
L6211 |
25 ml |
|
in PBS without Ca2+
/ Mg2+ |
|
|
|
for mitosis inhibition |
|
|
|
|
|
|
|
COLCEMIDE (Demecolcine) |
L6221
|
25 ml |
|
10 μg / ml in PBS without Ca2+ / Mg2+ |
|
|
|
for mitosis inhibition |
|
|
|
|
|
|
|
COLCEMIDE (Demecolcine) |
L6231 |
25 ml |
|
10 μg / ml in Hanks' saline |
|
|
|
for mitosis inhibition |
|
|
Safety precautions:
·
after contact with skin, wash immediately with plenty of water
·
wear suitable, protective clothing
·
in case of an accident, seek medical advice immediately
![]()
INSTRUCTIONS FOR CHROMOSOME ANALYSIS
Blood samples should be token (sufficient cannular diameter, reduced
aspiration), as to ovoid haemolysis.
1. Under appropriate (sterile) conditions, approx. 0.5 ml
(25 - 30 drops) of heparinized venous whole blood are added and carefully mixed
with 8 ml of Chromosome Medium B (or 8 ml of Chromosome medium A +0.08 ml PHA L
(cat no M5030) in a tube. Cultivation time should be 72 hrs at +35 – 37oC.
2. 0.4 ml of Colchicin/Colcemide (10 μg/ml)
(cat.nos. L6211 / L6221) are added (corresponding to 0.48 μg/ml of medium
concentration); incubate for an additional 2 hrs.
3. Cells are centrifuged for 5 min at approx. 1000 rpm.
Remove supernatant and resuspend cells in 5 ml of hypotonic potassium
chloride(0.075M) (cat. no. L6413). Incubate for another 12 min at +35 - +37oC
and centrifuge the culture at 1000 rpm for 10 min.
4. Discard all but 0.25 ml of the supernatant, resuspend
cells in the remaining fluid.
5. Add 5 ml of freshly prepared, ice-cold fixative
(glacial acetic acid/methanol 1:3) dropwise to the cell suspension white gently
moving the flask. Allow resting for 10 min at +2 - +8oC.
6. Centrifuge at
7. Following another centrifugation, cells will become
visible as a slightly cloudy suspension (approx. 0.5 - 1 ml). Drop 3 - 5 drops
of cell suspension from a
8. Air-dried slides con be stained readily using the Orcein
or Giemsa staining technique.
![]()
Storage: -20oC
Optimized for the production of monoclonal
antibodies.
Reference:
Peters. J.H et.al. Monocioncil
Anlibodies - Preparation
and Characterization.
Springer [1985]
|
NaCl |
6160 |
2 |
|
|
KCl |
400 |
Guanine•HCl |
0.06 |
|
Na2HPO4•7H2O |
1210 |
0.06 |
|
|
NaH2PO4•H2O |
28 |
0.06 |
|
|
Ca(NO3)•4H2O |
80 |
Uracil |
0.06 |
|
MgS04•7H2O |
120 |
0.06 |
|
|
CaCl2 |
40 |
|
|
|
1800 |
0.2 |
||
|
Phenol
red |
12.1 |
0.04 |
|
|
2040 |
Ascorbic acid |
0.01 |
|
|
|
|
0.162 |
|
|
5 |
Calciferol |
0.02 |
|
|
171.5 |
0.202 |
||
|
L-aspartic acid |
22 |
Choline
chloride |
2.5 |
|
0.02 |
0.802 |
||
|
56 |
28.01 |
||
|
260 |
0.002 |
||
|
L-glutamic acid |
69.6 |
Nicotinic acid |
0.005 |
|
18 |
Nicotinic acid amide |
0.805 |
|
|
15.2 |
0.81 |
||
|
18 |
Pyridoxal•HCl |
0.005 |
|
|
44 |
Pyridoxine•HCl |
0.805 |
|
|
52 |
0.162 |
||
|
46 |
Thiamine•HCl |
0.802 |
|
|
15 |
DL-α-tocopherol phosphate Na2 |
0.002 |
|
|
17 |
Vitamin A |
0.02 |
|
|
24 |
0.04 |
||
|
29 |
0.1 |
||
|
22 |
0.1 |
||
|
6 |
Vitamin B12 |
0.004 |
|
|
24 |
|||
|
21 |
|
|
|
|
0.81 |
|
|
|
|
Sodium acetate |
10 |
|
|
|
Fe(N03)3•9H2O |
0.14 |
|
|
|
Polysorbate 80 VG |
4 |
|
|
Different from the
original formulation, only 0.05 mg/1 riboflavin are used due to danger of photo
oxidation.
|
|
Cat.No. |
Unit
|
|
Hybridoma medium |
F5515 |
500 ml |
|
without HAT, with L-glutamine, |
|
|
|
with 10% FBS |
|
|
![]()
- Serum free medium for mammalian cells -
Storage: -20oC
The medium was
developed to effectively grow hybridomas, but is also suitable for other cell
lines. It is based on a 1:1 mixture of Iscove's
medium and Ham's F-12, supplemented with transferrin,
insulin, and a BSA/oleic acid complex.
Myelomas, hybridomas and also other lymphoid
and non-lymphoid cell lines are cultivated in Hybridomed
and show growth rates comparable to those observed in serum-supplemented media.
Successfully cultivated cells include: YAC-1 (mouse
T-cell lymphoma), HeLa (human epitheloid carcinoma), BJA-B (human EVB-negative myeloma), BHK21 (syrian
hamster kidney) and L-psv 129 (mouse
L-fibroblast).The medium is available for both 5 % and 10 % CO2
atmosphere- For use in bioreactors or to cultivate delicate normal ceils, we
recommend cat. no. F 8035 (CO2 should be
10 % to reach physiological pH values). With incubators adjusted at 5 % CO2, F8055 is recommended. This medium
has a reduced level of NaHCO3 and contains 3 g/l HEPES additionally.
Formulation (in mg/l)
Reference:
Jager,V., Lehmann,
J. and Friedl,P. Cytolechnology 1,
319 [1988]
|
CaCl2•H2O |
131.55 |
L-alanine |
17 |
|
CuSO4•5H2O |
0.00125 |
L-arginine•HCl |
100 |
|
FeSO4•7H2O |
0.417 |
L-asparagine•H2O |
40 |
|
KCl |
277 |
L-aspartic acid |
36 |
|
KNO3 |
0.038 |
L-cysteine•HCl•H2O |
17.5 |
|
MgSO4•7H2O |
100.04 |
L-cystine |
35 |
|
MgCl2•6H2O |
61.5 |
L-glutamic acid |
80 |
|
NaCl |
5800 |
L-glutamine |
438.6 |
|
Na2HPO4 |
54.5 |
Glycine |
30 |
|
NaH2PO4•H2O |
81.67 |
L-histidine•HCl•H2O |
30 |
|
NaSeO3 |
0.01 |
L-isoleucine |
105 |
|
ZnSO4•7H2O |
0.431 |
L-leucine |
105 |
|
NaHCO3 |
3610 |
L-lysine•HCl |
120 |
|
|
|
L-methionine |
36 |
|
D-Biotin |
0.0101 |
L-phenylalanine |
50 |
|
Choline
chloride |
8.98 |
L-proline |
37.25 |
|
Folic
acid |
2.66 |
L-serine |
52.5 |
|
Myo-inositol |
12.6 |
L-threonine |
77.25 |
|
Nicotinamide |
2.0 |
L-tryptophane |
15 |
|
D-Ca-pantothentate |
2.24 |
L-tyrosine |
52.31 |
|
Pyridoxine•HCl |
0.031 |
L-valine |
70 |
|
Pyridoxal•HCl |
2.0 |
|
|
|
Riboflavin |
0.219 |
Hypoxanthine |
2.04 |
|
Thiamine•HCl |
2.17 |
Thymidine |
0.365 |
|
Vitamin B12 |
0.6865 |
Linoleic acid |
0.042 |
|
D-glucose |
3650 |
Putrescine•HCl |
0.0805 |
|
Na-pyruvate |
330 |
Lipoic acid |
0.105 |
|
2-aminoethanol |
1.2 |
Phenol red Na |
8.586 |
|
|
|
|
|
|
|
|
Protein
supplements: |
|
|
|
|
Bovine insulin |
10 |
|
|
|
Bovine
transferring (iron saturated) |
10 |
|
|
|
Bovine serum
albumin free of fatty acids |
1000 |
|
|
|
oleic acid |
8 |
Different from the original formulation, only 0.05
mg/1 riboflavin are used due to avoid negative photo oxidative effects.
|
|
Cat.No. |
Unit
|
|
HybridoMed DIF 1000 |
F8035/1 |
500 ml |
|
with L-glutamine |
|
|
|
with NaHCO3 |
|
|
|
for 10% CO2 |
|
|
|
|
|
|
|
HybridoMed DIF 1000 |
F8055/1 |
500 ml |
|
with L-glutamine |
|
|
|
with NaHCO3 and HEPES |
|
|
|
for 5% CO2 |
|
|
![]()
Storage: +2 - +
The defined medium
well supports the growth of normal human keratinocytes if supplemented with
EGF, insulin, hydrocortisone, ethanolamine, and phospho-ethanolamine. Instead
of these. Fetal Bovine Serum (FBS) can serve as a general supplement. A 5 % CO2
atmosphere is recommended.
Formulation (in mg/1)
Reference.
Boyce, S.T. and Ham,
R.G. J. of Invest. Dermatol. 81, 33 [1983]
|
NaCl |
7599 |
Choline chloride |
13.96 |
|
KCl |
111.83 |
Putrescine |
0.1611 |
|
Sodum acetate•3H2O |
500 |
Vitamin
B12 |
4.07 |
|
Na2HPO4•7H2O |
536.2 |
Biotin |
0.0146 |
|
MgCl2•6H2O |
122 |
Calciumpantothenate |
0.258 |
|
CaCl2•2H2O |
4.411 |
Nicotinamide |
0.03663 |
|
Glucose |
1081 |
Pyridoxin•HCl |
0,06171 |
|
Na-pyruvate |
55 |
Thiamine•HCl |
0.3373 |
|
NaHCO3 |
1176 |
Adenine |
24.32 |
|
Phenol red |
1.377 |
Myo-inositol |
18.02 |
|
HEPES |
6600 |
Lipoic acid |
0.2063 |
|
|
|
Thymidine |
0.7266 |
|
L-alanine |
8.91 |
Folic acid |
0.79 |
|
L-arginine•HCl |
2107 |
Riboflavin |
0.03764 |
|
L-asparagine |
15.01 |
|
|
|
L-aspartic acid |
3.99 |
CuSO4•5H2O |
0.0002496 |
|
L-cysteine•HCl•H2O |
42.04 |
FeSO4•7H2O |
1.39 |
|
L-glutamine |
877.2 |
MnSQ4•5H2O |
0.000241 |
|
L-glutamic
acid |
14.71 |
(NH4)6Mo7O24•4H2O |
0.001236 |
|
Glycine |
7.51 |
NiC12•6H2O |
0.0001188 |
|
L-histidne•HCl•H2O |
16.77 |
H2SeO3 |
0.003869 |
|
L-isoleucine |
1.968 |
Na2SiO3•9H2O |
0.1421 |
|
L-leucine |
65.6 |
SnCl2•2H2O |
0.0001128 |
|
L-lysine•HCl |
18.27 |
NH4VO3 |
0.000585 |
|
L-rnethionine |
4.476 |
ZnSO4•7H2O |
0.144 |
|
L-phenylalanine |
4.956 |
|
|
|
L-proline |
34.53 |
|
|
|
L-serine |
63.06 |
|
|
|
L-threonine |
11.91 |
|
|
|
L-tryptophane |
3.06 |
|
|
|
L-tyrosine |
2.718 |
|
|
|
L-valine |
35.13 |
|
|
|
|
Cat.No. |
Unit
|
|
MCDB 153 liquid medium |
F8105 |
500 ml |
|
without L-glutamine |
|
|
|
|
|
|
![]()
Storage: <-
The serurn free medium was supplemented ready-to-use,
to support the growth of human normal keratinocytes.
Formulation (in mg/l)
|
NaCl |
7599 |
Choline chloride |
13.96 |
|
KCl |
111.83 |
Putrescine |
0.1611 |
|
Sodum
acetate•3H2O |
500 |
Vitamin B12 |
4.07 |
|
Na2HPO4•7H2O |
536.2 |
Biotin |
0.0146 |
|
MgCl2•6H2O |
122 |
Calciumpantothenate |
0.258 |
|
CaCl2•2H2O |
4.411 |
Nicotinamide |
0.03663 |
|
Glucose |
1081 |
Pyridoxin•HCl |
0,06171 |
|
Na-pyruvate |
55 |
Thiamine•HCl |
0.3373 |
|
NaHCO3 |
1176 |
Adenine |
24.32 |
|
Phenol red |
1.377 |
Myo-inositol |
18.02 |
|
HEPES |
6600 |
Lipoic acid |
0.2063 |
|
|
|
Thymidine |
0.7266 |
|
L-alanine |
8.91 |
Folic acid |
0.79 |
|
L-arginine•HCl |
2107 |
Riboflavin |
0.03764 |
|
L-asparagine |
15.01 |
|
|
|
L-aspartic acid |
3.99 |
CuSO4•5H2O |
0.0002496 |
|
L-cysteine•HCl•H2O |
42.04 |
FeSO4•7H2O |
1.39 |
|
L-glutamine |
877.2 |
MnSQ4•5H2O |
0.000241 |
|
L-glutamic acid |
14.71 |
(NH4)6Mo7O24•4H2O |
0.001236 |
|
Glycine |
7.51 |
NiC12•6H2O |
0.0001188 |
|
L-histidne•HCl•H2O |
16.77 |
H2SeO3 |
0.003869 |
|
L-isoleucine |
1.968 |
Na2SiO3•9H2O |
0.1421 |
|
L-leucine |
65.6 |
SnCl2•2H2O |
0.0001128 |
|
L-lysine•HCl |
18.27 |
NH4VO3 |
0.000585 |
|
L-rnethionine |
4.476 |
ZnSO4•7H2O |
0.144 |
|
L-phenylalanine |
4.956 |
|
|
|
L-proline |
34.53 |
<rh>
Epidermic growth factor |
0.005 |
|
L-serine |
63.06 |
Bovine Insulin
(Zn Salt) |
5.0 |
|
L-threonine |
11.91 |
Hydrocortisone |
0.5 |
|
L-tryptophane |
3.06 |
Ethanolamine |
6.108 |
|
L-tyrosine |
2.718 |
Phosphoethanolamine |
4.1 |
|
L-valine |
35.13 |
|
|
|
|
Cat.No. |
Unit
|
|
MCDB 153 complete |
F8115 |
500 ml |
|
with L-glutamine |
|
|
|
with 1.176 g/l NaHCO3 |
|
|
![]()
- MEDIUM FOR HUMAN SEBOCYTES -
Modified DMEM/HAm's F-12 (1:1), was optimized to grow the human
sebaceous gland cell line SZ95 in vitro The cell line itself was
developed by transfecting primary human facial sebocytes. A defined medium
formulation (in particular of the complete version) allows detailed studies under
controlled conditions on the influence of hormones, cytokines, lipids, and
drugs on human sebocytes.
The formulation is patent protected, and available on request.
Reference:
Zouboulis Chc et al Establishment and charocterization of an immortalized human sebaceous
gland cell line (SZ95) J. Invest Dermatol. 113, 101(1999)
|
|
Cat.No. |
Unit
|
|
sebomed basal
medium |
F8205 |
500 ml |
|
storage: + 2 - + 8 oC |
|
|
For optimal performance, this basal medium needs to be supplemented with
0.1 ng/ml Epidermal Growth Factor (EGF rh; cat. no, W0001 - 500), and 0.1 ml/ml
Fetal Bovine Serum. Gentamycin sulphate at a concentration of 50 μg/ml
should be used to protect against bacterial contamination.
|
|
Cat.No. |
Unit
|
|
sebomed complete
medium |
F8215 |
500 ml |
|
storage: - 20 oC |
|
|
|
|
|
|
|
Basal medium supplemented with |
|
|
|
|
|
|
|
2.0 g/l NaHCO3 |
|
|
|
50 mg bovine pituitary extract
(BPE) |
|
|
|
50 μg/l epidermal growth
factor (EGF <rh>) |
|
|
|
1 g/l fatty acid free bovine
serum albumin (BSA) |
|
|
|
0.15 μM linoleic acid |
|
|
![]()
Storage: +2 - +8oC
With this serum and protein free medium, VERO cells proliferate without
prior adaptation. VERO cells in protein free culture provide a sensitive
substrate for the propagation.of human pathogenic viruses. Cells were infected
by several viruses (Coxsackie B4, Herpes simplex type 1 and 2, measles, and polio, type 1 to 3). Virus titres were
comparable to those obtained in serum-supplemented media (see table). Due to
the very high calcium content of the medium, minor precipitates may
occasionally be observed. However, this does not influence cell growth rates.
Virus yield in VERO cells grown in protein free PFEK-1 medium, and in
medium* containing serum.
Virus titre (TCID50/ml)**
|
Virus type |
VERO-cells,
protein free |
VERO-cells, |
|
|
|
|
|
medium
supplemented with serum |
|
|
I *** |
II **** |
|
|
Coxsackie
B4 |
6.3 x 108 |
7.8 x 108 |
5.9 x 108 |
|
HSV-1 |
2.1 x 108 |
8.9 x 107 |
1.5 x 108 |
|
HSV-2 |
3.4 x 107 |
4.1 x 107 |
3.1 x 107 |
|
Measles |
7.9 x 105 |
1.2 x 106 |
9.8 x 105 |
|
Polio
1 |
4.3 x 108 |
5.1 x 108 |
6.6 x 108 |
|
Polio
2 |
1.2 x 108 |
9.4 x 107 |
4.8 x 108 |
|
Polio
3 |
8.5 x 107 |
7.8 x 107 |
9.2 x 107 |
* Cinatl, J.jr., J
Cinatl, H.Robenau, J,Rapp, B.Kornhuber, H.-w.Doerr Protein Free.Culture
of VERO cells:
A substrate for Replication of Human Pathogenic
Viruses, Cell Biology International 17 (9), 885 [1993]
**TCID 50, 50% tissue infective dosis
*** Virus titer obtained without former passage in
protein free medum
**** Virus titer after four passages in VERO cells
cultivated in PFEK-1 Medium
Formulation
(in mg/l)
|
L-glutamine |
292 |
NaF |
0.003 |
|
NaCl |
7179.5 |
NaSeO3•5H2O |
0.00228 |
|
KCl |
310 |
Na2SiO3•9H2O |
0.004 |
|
Na2HPO4 |
40 |
ZnSO4•7H2O |
0.5 |
|
MgSO4•7H2o |
45.5 |
FeSO4•7H2O |
0.4 |
|
MgCl2•6H2O |
62 |
Fe(NO3)3•9H2O |
0.1 |
|
CaCl2•2H2O |
486 |
CuSO4•5H2O |
0,0025 |
|
MES |
3150 |
CoC12•6H2O |
0.001 |
|
NaHCO3 |
2250 |
BaCl2•2H2O |
0.0023 |
|
D-glucose |
3650 |
LiCl |
2.5 |
|
D-ribose |
0.2 |
|
|
|
Na-pyruvate |
85 |
EDTA Na |
4.3 |
|
Phenol red Na |
6.36 |
Glutathione |
0.03 |
|
|
|
Guanine•HCl |
0.1 |
|
D-biotin |
0.06 |
Hypoxanthine |
4.1 |
|
Calciferol |
0.05 |
Linoleic acid |
0.084 |
|
D-panthotenate |
1.8 |
DL-lipoic acid |
0.65 |
|
Choline chloride |
7.5 |
Oxalic acetic
acid |
3 |
|
FAD•Na2 |
0.015 |
Progesterol |
0.004 |
|
Myo-inositol |
15 |
Putrescine•HCl |
0.0805 |
|
Nicotinamide |
4.5 |
Na2(Fe(CN)5NO)•2H2O |
3 |
|
Nicotinic acid |
0.02 |
Taurine |
20 |
|
p-amino benzoic
acid |
0.02 |
Thymidine |
0.75 |
|
Pyridoxal•HCl |
1 |
Polysorbate 80 VG |
2.5 |
|
Pyridoxin•HCl |
0.1 |
Riboflavin |
0.025 |
|
Vitamin A acetate |
0.08 |
Folic acid |
1.2 |
|
Thiamine•HCl |
0.3 |
|
|
|
DL-tocopherol
acetate |
0.1 |
Na2MoO4•2H2O |
0.00005 |